Please login to the form below

Not currently logged in
Email:
Password:

Media planning and buying

This Media planning and buying section features Media planning and buying companies, .

Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal approach. From planning and buying to analytics, research and strategy, we're the leading specialists in pharmaceutical and healthcare media. Wherever you want your media to take you, we can make it happen. Our partnerships around the world mean we can offer a truly global solution. Our expertise allows us to deliver targeted global campaigns featuring multiple channels, languages and creative executions, informed, insightful and versatile media. Four Health Media is part of Four Health.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

HEAL [International] Ltd

A unique alliance of the leading independent healthcare media agencies in the key European markets and USA, we deliver unparalleled pan-European and international media campaigns for pharma and healthcare clients of all sizes.

Healthcare Media Europe – HME

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering media and content driven engagement solutions for the Global Healthcare industry.

MMS360

MMS are specialists in healthcare media strategy. Building audience engagement is at the core of our ethos. We believe that to deliver true value, media communications must be built upon robust audience understanding. We work closely in partnership with our clients to provide strategic insight into audience needs and media consumption. We convert information into valuable insight to inform and strengthen your media strategy.

Nitro Digital

Nitro Digital is an award-winning full service digital marketing agency focused on the life science sector. We offer a strategic approach to meeting your commercial objectives online across the full multi-channel that includes innovative and effective use of social media to target, reach and engage with your audience in order to change behaviour. Our approach to research is key. Without understanding the landscape online, and the needs of your users our creative, design and technology solutions would not work. We passionately believe in the customer experience, whether it’s the one that we’re designing for your users or the one that we manage to make the digital delivery an amazing one for you. We work hard to build long-term working relationships with our clients, their agencies and our partners.

Wrigley Foster Media Direct Limited

UK Pan European and Global Media Solutions for the healthcare and pharmaceutical industry.

1

Featured jobs

Latest content from PMHub

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement. COUCH.
Is agile working benefiting the employee or the organisation?
Angela Young, HR Director Lucid Group discusses the pros and cons of agile working in the latest “Smart Thinking” blog on pmlive.com Lucid Group Communications Limited
Putting the patient first
You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch. Data has been collected, efficacy is understood and side effects are recorded. But an important question remains: is your target patient population prepared? Ashfield
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the challenges that come with developing products in this complex market. Blue Latitude Health